OCE is elementary school age already?

🚬🦬🌹

The latest on the BIOSECURE Act from our Sarah Karlin-Smith ...Pink Sheet, Citeline Regulatory #pinksheet #pharma: Who Will Reap The BIOSECURE Spoils? US Industry Boost Not Guaranteed pink.citeline.com/articles/2024/…

Our Sue Sutter has the latest on Friday's U.S. FDA adcomm ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: Intercept’s Ocaliva Falls At US FDA Panel; Is Accelerated Approval Withdrawal On The Horizon? pink.citeline.com/articles/2024/…

Here's part 3 of Sue Sutter's Vafeso drug review profile ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: US FDA Review Of Akebia’s Vafseo Informed By Roxadustat, Daprodustat Safety Concerns pink.citeline.com/articles/2024/…

ICYMI on Friday (And NO PAYWALL!) ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: Pink Sheet Podcast: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging pink.citeline.com/articles/2024/…

The FDA has thoughts on how to run multi-regional trials ... Pink Sheet, Citeline Regulatory Sue Sutter #pinksheet #pharma: The Anti-Sintilimab Guidance? US FDA Gives Advice On Oncology Multiregional Trials pink.citeline.com/articles/2024/…

This is a little surprising ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: Drug Pricing And The US Presidential Campaign: A Non-Issue? pink.citeline.com/articles/2024/…

More on BIOSECURE Act ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: Geopolitics, US BIOSECURE: Pharma Looks To Redistribute CDMO Footprint pink.citeline.com/articles/2024/…

Dust off your resumes quickly. Applications are due by Sept. 20. This is one of my stories ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: US FDA’s CBER Seeks Associate Director Overseeing Rare Disease Work pink.citeline.com/articles/2024/…

Really interesting trend emerging here ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: Evergreen With Envy: Halozyme’s Subcutaneous Conversions Grow As Rivals Hope To Break In pink.citeline.com/articles/2024/…

Also interesting ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: Shot Across The Bow? Express Scripts Lawsuit Aims To Prevent Fall-Out From FTC PBM Report pink.citeline.com/articles/2024/…

The U.S. FDA is making news at RAPS Convergence 2024 ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: Model-Informed Drug Development Program Could Handle More Requests, But US FDA Needs Funding pink.citeline.com/articles/2024/…

For your clinical trial diversity radar ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: How The UK, EU, Canada, Australia And Japan Are Tackling Diversity In Clinical Trials pink.citeline.com/articles/2024/…

For your clinical trial radar, from our Sarah Karlin-Smith ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: Integrating Trials Into Clinical Practice: US FDA Guidance Outlines Limited Use Cases pink.citeline.com/articles/2024/…

Interesting ... Pink Sheet, Citeline Regulatory #pinksheet #pharma: A Rare Good Day For PBMs On Capitol Hill pink.citeline.com/articles/2024/…

A monoclonal antibody that can bind to the underside of influenza viral neuraminidase is available for licensing from the NIH #pharma: public-inspection.federalregister.gov/2024-21742.pdf

Interesting ... marie dunphy #pharma: FTC Targets PBMs In Lawsuit On Insulin Rebates But Says Pharma Also Culpable pink.citeline.com/articles/2024/…

The antibiotic incentives aren't there. Another story from our Sarah Karlin-Smith ... marie dunphy #Pharma: Stark Reminders Of Why Antibiotic Space Remains Unattractive On Display At FDA Advisory Cmte. pink.citeline.com/articles/2024/…

More on the decentralized trials guidance from Sue Sutter ... #pinksheet #pharma Pink Sheet, Citeline Regulatory Decentralized Trials: FDA Final Guidance Eliminates Need For Local Provider Activity Tracking pink.citeline.com/articles/2024/…